News Updates

Centre Asks Patanjali To Stop Advertisements About Unverified Ayurveda Medicine Developed To Cure Covid-19

23 Jun 2020 1:51 PM GMT
Centre Asks Patanjali To Stop Advertisements About Unverified Ayurveda Medicine Developed To Cure Covid-19
Your free access to Live Law has expired
To read the article, get a premium account.
    Your Subscription Supports Independent Journalism
Subscription starts from
(For 6 Months)
Premium account gives you:
  • Unlimited access to Live Law Archives, Weekly/Monthly Digest, Exclusive Notifications, Comments.
  • Reading experience of Ad Free Version, Petition Copies, Judgement/Order Copies.
Already a subscriber?

The Union Ministry of AYUSH has taken suo moto cognizance of the media reports about Ayurvedic medicines developed by Patanjali Ayurved Ltd. for treatment of Covid-19.

The Ministry has clarified that facts of the claim and details of the stated scientific study are not known to it, are uncorroborated and it has therefore asked the company to stop advertising such claims.

The Ministry has asked the company to refrain from making such claims until they are duly verified by the concerned authorities.

It has informed the Company that such advertisements of drugs, including Ayurvedic medicines, are regulated under the provisions of Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules thereunder.

Meanwhile, the Ministry has also requested concerned State Licensing Authority of Uttrakhand Government to provide copies of license and product approval details of the Ayurvedic medicines being claimed for the treatment of COVID -19.

For the purposes of verification, the Government has asked Patanjali Ayurved to disclose:

  • the name and composition of the medicines being claimed for COVID treatment;
  • site(s)/hospital(s), where the research study was conducted for COVID-19;
  • protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results data of the study(ies).

It may be noted that the Ministry had issued a Gazette Notification on April 21, 2020, stipulating all the requirements and the manner in which the research studies on COVID-19 have to be undertaken, with Ayush interventions/medicines.

Earlier this year, the AYUSH Ministry had permitted clinical trials of four ayurvedic medicines for the treatment of the disease. The company has now launched 'Coronil and Swasari', claiming that the medicines showed "100% favourable results" during clinical trials.

"We are launching COVID medicines Coronil and Swasari today. We conducted two trials of these, first clinical controlled study, which took place in Delhi, Ahmedabad, among many other cities. Under this 280 patients were included and 100 per cent of those recovered. We were able to control Corona and its complications in this. After this the all-important clinical control trial was conducted," Yoga Guru Ramdev said at the press conference.

Next Story
Share it